In a new study published in Nature, researchers at the University of Chicago Medicine Comprehensive Cancer Center explore a ...

Gene therapy stocks like CRISPR Therapeutics and ... A single clinical trial failure might derail the whole thesis, as the technology needs to pass a series of trials to demonstrate efficacy ...

To remain relevant in an interconnected ecosystem, biopharma must go beyond optimising yesterday’s markets and begin ...

Orphan drug developers face significant difficulties when navigating market access frameworks in Europe. Could greater use of ...

The University of California and the University of Vienna on Monday convinced a U.S. appeals court to revive their bid for ...

A favorable appeals court ruling repositioned a coalition of universities and Nobel laureates to win credit for inventing a ...

A federal appeals court said the patent office made legal errors in awarding foundational patents for CRISPR-Cas9 to the ...

Researchers at the University of Minnesota have completed a first-in-human clinical trial testing a CRISPR/Cas9 gene-editing technique to help the immune system fight advanced gastrointestinal (GI) ...

Scientists used CRISPR tech to create a custom-made drug targeted at helping a newborn baby fight a rare genetic disorder. According to an extraordinary new paper published in The New England ...

The only gene-editing therapy currently on the market is a CRISPR–Cas9-based treatment for two blood disorders, sickle-cell ...